ESTA Establishment Labs Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ESTA

Price (delayed)

$77.74

Market cap

$2.29B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.48

Enterprise value

$2.47B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 38

Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative ...

Highlights
Establishment Labs Holdings's EPS has soared by 52% YoY and by 14% from the previous quarter
The net income has surged by 51% year-on-year and by 14% since the previous quarter
Establishment Labs Holdings's equity has shrunk by 62% YoY and by 37% QoQ
ESTA's debt is up by 12% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: https://establishmentlabs.com
Peers: STE SYK

Key stats

What are the main financial stats of ESTA

ESTA stock price

How has the Establishment Labs Holdings stock price performed over time
Intraday
7.36%
1 week
6.52%
1 month
10.68%
1 year
109.09%
YTD
6.67%
QTD
36.91%

Financial performance

How have Establishment Labs Holdings's revenue and profit performed over time
Revenue
$229.58M
Gross profit
$160.84M
Operating income
-$28.57M
Net income
-$43.74M
Gross margin
70.1%
Net margin
-19.1%
ESTA's operating margin has surged by 64% year-on-year and by 33% since the previous quarter
ESTA's net margin has surged by 63% year-on-year and by 21% since the previous quarter
The operating income has soared by 51% year-on-year and by 27% since the previous quarter
The net income has surged by 51% year-on-year and by 14% since the previous quarter

Price vs fundamentals

How does ESTA's price correlate with its fundamentals

Growth

What is Establishment Labs Holdings's growth rate over time

Valuation

What is Establishment Labs Holdings stock price valuation
P/E
N/A
P/B
154.19
P/S
10.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.76
Establishment Labs Holdings's EPS has soared by 52% YoY and by 14% from the previous quarter
The price to book (P/B) is 75% higher than the last 4 quarters average of 82.3 and 55% higher than the 5-year quarterly average of 92.4
Establishment Labs Holdings's equity has shrunk by 62% YoY and by 37% QoQ
Establishment Labs Holdings's revenue has increased by 35% YoY and by 9% from the previous quarter
The P/S is 23% more than the last 4 quarters average of 7.7

Efficiency

How efficient is Establishment Labs Holdings business performance
Establishment Labs Holdings's ROS has soared by 72% YoY and by 30% from the previous quarter
Establishment Labs Holdings's return on invested capital has surged by 66% YoY and by 26% QoQ
The company's return on assets has surged by 56% YoY and by 15% QoQ
The ROE has contracted by 12% from the previous quarter and by 7% YoY

Dividends

What is ESTA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ESTA.

Financial health

How did Establishment Labs Holdings financials performed over time
The company's total assets is 4.4% higher than its total liabilities
ESTA's total liabilities is up by 14% year-on-year
Establishment Labs Holdings's current ratio has decreased by 12% YoY and by 2.6% from the previous quarter
The debt to equity has soared by 192% YoY and by 60% from the previous quarter
Establishment Labs Holdings's equity has shrunk by 62% YoY and by 37% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.